Chronomics: Circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond

Journal of Experimental Therapeutics and Oncology

Volumn 3, Issue 5, 2003, Pages 223-260

  Halberg, Franz ^a   Cornélissen, Germaine ^a   Wang, Zhengrong ^b   Wan, Chaomin ^b   Ulmer, Waldemar ^c   Katinas, George ^a   Singh, Ranjana ^d   Singh, R K ^d   Singh, Rajesh Kumar ^d   Gupta, B D ^e   Singh, R B ^f   Kumar, Adarsh ^g   Kanabrocki, Eugene ^h   Sothern, Robert B ^a   Rao, Gundu ^a   Bhatt, Madan L B ^d   Srivastava, Madhu ^d   Rai, Gulshan ^d   Singh, Subhash ⁱ   Pati, Atanu Kumar ^j   Nath, Panchanan ^j   Halberg, Francine ^k   Halberg, Julia ^l   Schwartzkopff, Othild ^a   Bakken, Earl ^m   Shastri, Shri Vishnu Kant ⁿ   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b SICHUAN UNIVERSITY   (China)

^c VARIAN MEDICAL SYSTEMS   (Switzerland)

^d KING GEORGE'S MEDICAL UNIVERSITY   (India)

^e Dr Vikrant Gupta Mem Foundation   (India)

^f Medical Hospital and Research Centre Moradabad   (India)

^g GOVERNMENT MEDICAL COLLEGE   (India)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^j PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

^k Marin Radiation Oncology Medical Group   (United States)

^l GENERAL MILLS INC   (United States)

^m North Hawaii Community Hospital Incorporated   (United States)

ⁿ UP Governor House   (India)

more..

Author keywords

Chronome; Chronomics; Chronotherapy; Circadian; Circaseptan; Nutriceuticals

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CISPLATIN; CORTICOTROPIN DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN; MALONALDEHYDE; MELATONIN; MELPHALAN; SUPEROXIDE DISMUTASE; UBIQUINONE; URIC ACID; VINCRISTINE;

ANTIOXIDANT ACTIVITY; CALORIC INTAKE; CANCER RADIOTHERAPY; CARDIOVASCULAR RISK; CHRONOTROPISM; CIRCADIAN RHYTHM; DRUG ACTIVITY; HORMONE RELEASE; HUMAN; NONHUMAN; NUTRIENT; PERIODICITY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; ENERGY INTAKE; HUMANS; MELATONIN; NUTRITION PHYSIOLOGY; RADIOTHERAPY, ADJUVANT;

EID: 0346363808     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1533-869X.2003.01097.x     Document Type: Review

References (186)

1. Halberg F, Haus E, Cardoso SS, et al. Toward a chronotherapy of neoplasia: Tolerance of treatment depends upon host rhythms. Experientia (Basel) 29: 909-934, 1973.
2. Deka AC. Application of chronobiology to radiotherapy of tumours of the oral cavity. M.D. (Radiotherapy) Thesis, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 90 pp., 1975.
3. Halberg F, Gupta BD, Haus E, et al. Steps toward a cancer chronopolytherapy. In: Proceedings of the XIV International Congress of Therapeutics. Montpellier, France: L'Expansion Scientifique Française 151-196, 1977.
4. Halberg Francine, Halberg J, Halberg E, Halberg Franz. Chronobiology, radiobiology and steps toward the timing of cancer radiotherapy. In: Goldson AL, ed. Cancer Growth and Progression, Vol. 9, ch. 19, H. Kaiser series ed. Dordrecht: Kluwer Academic Publishers 227-253, 1989.
5. Sundararaj BI, Nath P, Halberg F. Circadian meal timing in relation to lighting schedule optimizes catfish body weight gain. J Nutr 12: 1085-1097, 1982.
6. Halberg F. Protection by timing treatment according to bodily rhythms: an analogy to protection by scrubbing before surgery. Chronobiologia 1 (Suppl. 1): 27-68, 1974.
7. Halberg F, Haus E, Cornélissen G. From biologic rhythms to chronomes relevant for nutrition. In: Marriott BM, ed. Not Eating Enough: Overcoming Underconsumption of Military Operational Rations. Washington, DC: National Academy Press 361-372, 1995.
8. Singh R. Biochemical studies with chronobiological approach on the role of free radicals oxidants and antioxidants in the etiopathogenesis of pathological disorders. Ph.D (Medical Biochemistry) Thesis, C.S.M. Kanpur University, Kanpur, India, 2001, 347 pp (216 pp text, 90 tables, 41 figures).
9. Singh RB, Srivastav V, Srivastav SSL, Akhilesh J, Cornélissen G, Halberg F. Circadian variation under conditions of caloric restriction in North India. Abstract 36, 2nd International Symposium: Workshop on Chronoastrobiology & Chronotherapy, Tokyo Kasei University, Tokyo, Japan, November 2001, unpaginated (1 p).
10. Singh Ranjana, Singh Rajesh K, Mahdi AA, et al. Circadian periodicity of plasma lipid-peroxides and other anti-oxidants as putative markers in gynecological malignancies. Neuroendocrinol Lett (in press).
11. Kanabrocki EL, Murray D, Hermida RC, et al. Circadian variation in oxidative stress markers in healthy and type II diabetic men. Chronobiol Int 19: 423-439, 2002.
12. Baydas G, Gursu MF, Yilmaz S, Canpolat S, Yasar A, Cikim G, Canatan H. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett 323: 195-198, 2002.
13. Pashkov AN, Nastausheva TL, Sitnikova VP, Riaskian LV. Circadian rhythms of urinary parameters in children with glomerulonephritis. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 8: 45-49, 2000.
14. Skrzypinska-Gawrysiak M, Piotrowski JK, Sporny S. Circadian variations in hepatotoxicity of carbon tetrachloride in mice. Int J Occup Med Environ Health 13: 165-173, 2000.
15. Rajakrishnan V, Subramanian P, Viswanathan P, Menon VP. Effect of chronic ethanol ingestion on biochemical circadian rhythms in Wistar rats. Alcohol 18: 147-152, 1999.
16. Subramanian P, Menon VP, Arokiam FV, Rajakrishnan V, Balamurugan E. Lithium modulates biochemical circadian rhythms in Wistar rats. Chronobiol Int 15: 29-38, 1998.
17. Hamulati, Abuduaini, Abudureyimu. Study on the pathogenesis of free radical in nocturnal asthma. Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih (Chinese J Tuberculosis Respir Dis) 21: 141-143, 1998.
18. Luo H, Guo H, Xiao J, Xue Z. Circadian variations of plasma SOD and MDA in healthy subjects. Hua-Hsi i Ko Ta Hsueh Pao (J West China Univ Med Sci) 28: 401-403, 1997.
19. Solar P, Toth G, Smajda B, Ahlers I, Ahlersova E. Circadian and circannual oscillations of tissue lipoperoxides in rats. Physiol Res 44: 249-256, 1995.
20. Skrzypinska-Gawrysiak M, Piotrowski JK, Bruchaizer E. The diurnal rhythm of hepatotoxic action of chloroform. Int J Occup Med Environ Health 8: 115-121, 1995.
21. Bridges AB, Scott NA, McNeill GP, Pringle TH, Belch JJ. Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Eur Heart J 13: 1632-1636, 1992.
22. Lapenna D, De Gioia S, Mezzetti A, et al. Circadian variations in antioxidant defences and lipid peroxidation in the rat heart. Free Radic Res Commun 17: 187-194, 1992.
23. Barkova EN, Korkin AL, Chesnokov EV. Sutochnaia dinamika ekskretsii zheleza s mochoi pri eksperimental'nom gepatoze [Daily dynamics of iron excretion with murine in experimental hepatosis]. Biulleten Eksperimentalnoi Biologii i Meditsiny 113: 124-126, 1992.
24. Schaper U, Holig K, Weber A, Scheuch DW. Tageszeitliche Veranderungen der Aktivitat der Superoxiddismutase (EC 1.15.1.1) und der Malondialdehydkonzentration im Gehirn und Striatum der Ratte [Diurnal variations in superoxide dismutase (EC 1.15.1.1) activity and malondialdehyde concentration in the rat brain and striatum]. Z Med Lab Diagn 27: 50-51, 1986.
25. Halberg F. Temporal coordination of physiologic function. Cold Spring Harb Symp Quant Biol 25: 289-310, 1960 [See discussion following paper on LD50 (of whole-body irradiation].
26. Pizzarello DJ, Witcofski RL, Lyons EA. Variations in survival time after whole-body irradiation at two times of day. Science 139: 349, 1963.
27. Pizzarello DJ, Isaak D, Chua KE, Rhyne AL. Circadian rhythmicity in the sensitivity of two strains of mice to whole-body irradiation. Science 145: 286-291, 1964.
28. Haus E, Halberg F, Loken MK. Circadian susceptibility-resistance cycle of bone marrow cells to whole-body X-irradiation in BALB/c mice. In: Scheving LE, Halberg F, Pauly JE eds. Chronobiology, Proceedings of the International Society for the Study of Biological Rhythms. Little Rock, Ark. Stuttgart: Georg Thieme Publishers/Tokyo: Igaku Shoin Ltd. 115-122, 1974.
29. Halberg F, Nelson W, Cornélissen G, Haus E, Scheving LE, Good RA. Chronochemotherapy: L1210 leukemia and beyond. Chronobiologia 6: 203-211, 1979.
30. Cavallini M, Halberg F, Cornélissen G, Enrichens F, Margarit C. Organ transplantation and broader chronotherapy with implantable pump and computer programs for marker rhythm assessment. J Control Release 3: 3-13, 1986.
31. Liu T, Cavallini M, Halberg F, Cornélissen G, Field J, Sutherland DER. More on the need for circadian, circaseptan and circannual optimization of cyclosporine therapy. Experientia 42: 20-22, 1986.
32. Halberg E, Halberg F. Chronobiologic study design in everyday life, clinic and laboratory. Chronobiologia 7: 95-120, 1980.
33. Cadenas E, Packer L, eds. Handbook of Antioxidants, 2nd edn. New York/Basel: Marcel Dekker Inc., 2002.
34. Reiter RJ, Tan D-x, Manchester LC, Calvo JR. Antioxidant capacity of melatonin. In: Cadenas E, Packer L, eds. Handbook of Antioxidants, 2nd edn. New York/Basel: Marcel Dekker Inc. 565-613, 2002.
35. Livrea MA, Tesoriere L, Tan D-x, Reiter RJ. Radical and reactive intermediate-scavenging properties of melatonin in pure chemical systems. In: Cadenas E, Packer L, eds. Handbook of Antioxidants, 2nd edn. New York/Basel: Marcel Dekker Inc. 615-631, 2002.
36. Reiter RJ. Potential biological consequences of excessive light exposure: melatonin suppression, DNA damage, cancer and neurodegenerative diseases. Neuroendocrinol Lett 23 (Suppl. 2): 9-13, 2002.
37. Cadenas E, Packer L, eds. Understanding the Process of Aging: The Roles of Mitochondria, Free Radicals, and Antioxidants. New York/Basel: Marcel Dekker Inc., 1999.
38. Keaney JF Jr, ed. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publishers, 2000.
39. Packer L, Rösen P, Tritschler HJ, King GL, Azzi A, eds. Antioxidants in Diabetes Management. New York/Basel: Marcel Dekker Inc., 2000.
40. Bartsch H, Bartsch C. Effect of melatonin on experimental tumors under different photoperiods and times of administration. J Neural Transm 52: 269-279, 1981.
41. Langevin T, Hrushesky W, Sanchez S, Halberg F. Melatonin (M) modulates survival of CD2F1 mice with L1210 leukemia. Chronobiologia 10: 173-174, 1983.
42. Halberg F, Sanchez de la Peña S, Wetterberg L, Halberg J, Halberg Francine, Wrba H, Dutter A, Hermida Dominguez RC. Chronobiology as a tool for research, notably on melatonin and tumor development. In: Pancheri P, Zichella L, eds. Biorhythms and Stress in the Physiopathology of Reproduction. New York: Hemisphere 131-175, 1988.
43. Wrba H, Halberg F, Dutter A. Melatonin circadian-stage-dependently delays breast cancer development in mice injected daily for several months. In: Neuroimmunomodulation, Proceedings of the 1st International. Workshop on NIM, Bethesda, MD, Nov. 27-30, 1984. Bethesda: IWGN 258-261, 1985.
44. Wrba H, Halberg F, Dutter A. Placebo-accelerated murine mammary carcinogenesis possibly partially reversed by melatonin. Chronobiologia 12: 285, 1985.
45. Wrba H, Dutter A, Sanchez de la Pena S, Cornélissen G, Halberg F. Secular or circadian effects of placebo and melatonin on murine breast cancer? Prog Clin Biol Res 341A: 31-40, 1990.
46. Sanchez de la Pena S. The feedsideward of cephalo-adrenal immune interactions. Chronobiologia 20: 1-52, 1993.
47. Halberg J. Catfish anyone? Chronobiologia 1: 127-129, 1974.
48. Nelson W, Cadotte L, Halberg F. Circadian timing of single daily "meal" affects survival of mice. Proc Soc Exp Biol (NY) 144: 766-769, 1973.
49. Halberg F, Halberg E, Carandente F. Chronobiology and metabolism in the broader context of timely intervention and timed treatment. In: Lindenlaub E, ed. Diabetes Research Today, Meeting of the Minkowski Prize Winners, Symposia Medica Hoechst 12 (Capri). Stuttgart/New York: F.K. Schattauer Verlag 45-95, 1976.
50. Halberg F. Chronobiology. Annu Rev Physiol 31: 675-725, 1969.
51. Refinetti R. Circadian Physiology. Boca Raton, Florida: CRC Press 184 pp (+1 computer disk), 1999.
52. Halberg F, Cornélissen G, Otsuka K, et al. Cross-spectrally coherent ∼10.5- and 21-year biological and physical cycles, magnetic storms and myocardial infarctions. Neuroendocrinol Lett 21: 233-258, 2000.
53. Halberg F, Cornélissen G, Otsuka K, Schwartzkopff O, Halberg J, Bakken EE. Chronomics. Biomed Pharmacother 55 (Suppl 1): 153-190, 2001.
54. Galileo (Drake S, trans). Two New Sciences: Including Centers of Gravity and Force of Percussion, 2nd edn. Toronto: Wall & Thompson, 1989 [For quotation also see http://www-history.mcs.st-andrews.ac.uk/history/Quotations/Galileo.htmlj.
55. Halberg F, Cornélissen G, Otsuka K, Katinas G, Schwartzkopff O. Essays on chronomics spawned by transdisciplinary chronobiology: Witness in time: Earl Elmer Bakken. Neuroendocrinol Lett 22: 359-384, 2001.
56. Skladowski K, Maciejewski B, Golen M, Pilecki B, Przeorek W, Tarnawski R. Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity. Radiother Oncol 55: 101-110, 2000.
57. Withers HR. Biologic basis of radiation therapy. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology, 2nd edn. New York: Lippincott 64-96, 1992.
58. Withers HR. Biological basis of radiation therapy for cancer. Lancet 339: 156-159, 1992.
59. Withers HR. Treatment-induced accelerated human tumor growth. Semin Radiat Oncol 3: 135-143, 1993.
60. Withers HR, Peters LJ, Taylor JMG. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31: 353-359, 1995.
61. O'Sullivan JM, Hollywood DP, Cody N, Dillon J, Buckney S, Moriarty MJ, Armstrong JG. Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer - a feasibility study. Clin Oncol (R Coll Radiol) 14: 236-240, 2002.
62. Halberg F. Chronobiology: methodological problems. Acta Med Rom 18: 399-440, 1980.
63. Cornélissen G, Halberg F. Chronomedicine. In: Armitage P, Colton T. (editors-in-chief). Encyclopedia of Biostatistics, v. 1. Chichester, UK: John Wiley & Sons Ltd 642-649, 1998.
64. Guerrero JM, Pablos MJ, Ortiz GG, Agapito MT, Reiter RJ. Nocturnal decreases in nitric oxide and cyclic GMP contents in the chick brain and their prevention by light. Neurochem Int 29: 417-421, 1996.
65. Reis F, Hermida RC, Souza I, et al. Circadian and seasonal variation of endogenous ubiquinone plasma level. Chronobiol Int 19: 599-614, 2002.
66. Cornélissen G, Halberg F, Perfetto F, Tarquini R, Maggioni C, Wetterberg L. Melatonin involvement in cancer: methodological considerations. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke W, eds. The Pineal Gland and Cancer: Neuroimmunoendocrine Mechanisms in Malignancy. Heidelberg: Springer 117-149, 2000.
67. Halberg F, Cornélissen G, Conti C, et al. The pineal gland and chronobiologic history: mind and spirit as feedsidewards in time structures for prehabilitation. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke W, eds. The Pineal Gland and Cancer: Neuroimmunoendocrine Mechanisms in Malignancy. Heidelberg: Springer 66-116, 2000.
68. Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke W, eds. The Pineal Gland and Cancer: Neuroimmunoendocrine Mechanisms in Malignancy. Heidelberg: Springer, 2000.
69. Wurtman RJ. Melatonin in humans. J Neurol Trans (Suppl) 21: 1-8, 1986.
70. Halberg F, Barnum CP, Silber RH, Bittner JJ. 24-hour rhythms at several levels of integration in mice on different lighting regimens. Proc Soc Exp Biol (NY) 97, 897-900, 1958.
71. Cornélissen G, Halberg F. Introduction to Chronobiology. Medtronic Chronobiology Seminar #7, April 1994, 52 pp. (Library of Congress Catalog Card #94-060580; URL [accessed 1994] http://www.msi.umn.edu/~halberg/)
72. Litman T, Halberg F, Ellis S, Bittner JJ. Pituitary growth hormone and mitoses in immature mouse liver. Endocrinology 62: 361-364, 1958.
73. Qu Yi, Wang ZR, Huang X, Wan CW, Yang CL, Liu BL, Cornélissen G, Halberg F. Circadian telomerase activity and DNA synthesis for timing peptide administration. Peptides 124: 363-369, 2003.
74. Bingham C, Arbogast B, Cornélissen Guillaume G, Lee JK, Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 9: 397-439, 1982.
75. Singh RB. Coenzyme Q10 and the brain-heart connection. In: Gvozdjakova A, Kucharska J, eds. Coenzyme Q10 and Mitochondrial Medicine, and International Symposium on Coenzyme Q10 in Biology and Medicine, April 23, 2002, Bratislava, Slovak Republic. Bratislava: Pharmacobiochemical Laboratory of Medical Faculty, Comenius University 1-3, 2002.
76. Singh RB, Kartik C, Otsuka K, Pella D, Pella J. Brain-heart connection and the risk of heart attack. Biomed Pharmacother 56 (Suppl 2): 257s-265s, 2002.
77. Halberg F, Cornélissen G, Otsuka K, Singh RB, Pella D. For coQ10 and generally, chronotherapeutic trials dismiss the myth that "larger is better". In: Gvozdjakova A, Kucharska J, eds. Coenzyme Q10 and Mitochondrial Medicine, and International Symposium on Coenzyme Q10 in Biology and Medicine, April 23, 2002, Bratislava, Slovak Republic. Bratislava: Pharmacobiochemical Laboratory of Medical Faculty, Comenius University 4-6, 2002.
78. Cornélissen G, Halberg Francine, Kessler T, et al. For coQ10 and generally: N-of-1 chronobiologic designs. In: Gvozdjakova A, Kucharska J, eds. Coenzyme Q10 and Mitochondrial Medicine, and International Symposium on Coenzyme Q10 in Biology and Medicine, April 23, 2002, Bratislava, Slovak Republic. Bratislava: Pharmacobiochemical Laboratory of Medical Faculty, Comenius University 7-12, 2002.
79. Halberg F, Bingham C, Cornélissen G. Clinical trials: the larger the better? Chronobiologia 20: 193-212, 1993.
80. Guenther R, Herold M, Halberg E, Halberg F. Circadian placebo and ACTH effects on urinary cortisol in arthritics. Peptides 1: 387-390, 1980.
81. Singh RK, Chansouria JPN, Udupa KN. Circadian periodicity of plasma cortisol (17-OHCS) levels in normal, traumatised, corticotrophin and dexamethasone treated rabbits. Ind J Med Res 63: 793-798, 1975.
82. Cornélissen G, Halberg F, Prikryl P, Dankova E, Siegelova J, Dusek J, International Womb-to-Tomb Chronome Study Group. Prophylactic aspirin treatment: the merits of timing. JAMA 266: 3128-3129, 1991.
83. Siegelova J, Fiser B, Dusek J, Sevela K, Halberg F, Cornélissen G. Circadian variability of blood pressure in patients with essential hypertension and nephrogenous hypertension treated with enalapril. Scripta Medica (Brno) 66: 99-104, 1993.
84. Halberg F, Cornélissen G, Bingham C, Fujii S, Halberg E. From experimental units to unique experiments: chronobiologic pilots complement large trials. In Vivo 6: 403-428, 1992.
85. Kennedy BJ. A lady and chronobiology. Chronobiologia 20: 139-144, 1993.
86. Halberg F, Cornélissen G, Katinas G, et al. System times and time horizons for biospheric near-matches of primarily non-photic environmental cycles. Biomed Pharmacother 56 (Suppl. 2): 266s-272s, 2002.
87. Halberg F, Cornélissen G, Wall D, et al. Engineering and governmental challenge: 7-day/24-hour chronobiologic blood pressure and heart rate screening: Part I. Biomed Instrum Technol 36: 89-122, 2002.
88. Halberg F, Cornélissen G, Wall D, et al. Engineering and governmental challenge: 7-day/24-hour chronobiologic blood pressure and heart rate screening: Part II. Biomed Instrum Technol 36: 183-197, 2002.
89. Halberg F, Cornélissen G, Watanabe Y, et al. Near 10-year and longer periods modulate circadians: intersecting anti-aging and chronoastrobiological research. J Gerontol A Biol Sci Med Sci 56: M304-M324, 2001.
90. Ulmer W, Cornélissen G, Halberg F. Physical chemistry and the biologic week in the perspective of chrono-oncology. In Vivo 9: 363-374, 1995.
91. Halberg F. Physiologic 24-hour periodicity: general and procedural considerations with reference to the adrenal cycle. Z. Vitamin-, Hormon-u Fermentforsch 10: 225-296, 1959.
92. Halberg F, Visscher MB. Regular diurnal physiological variation in eosinophil levels in five stocks of mice. Proc Soc Exp Biol (NY) 75: 846-847, 1950.
93. Halberg F, Visscher MB, Bittner JJ. Relation of visual factors to eosinophil rhythm in mice. Am J Physiol 179: 229-235, 1954.
94. Sundararaj BI, Vasal S, Halberg F. Circannual rhythmic ovarian recrudescence in the catfish Heteropneustes fossilis (Bloch). In: Takahashi R, Halberg F, Walker C, eds. Toward Chronopharmacology, Proceedings of the 8th IUPHAR Congress and Satellite Symposia, Nagasaki, July 27-28, 1981. Oxford/New York: Pergamon Press 319-337, 1982.
95. Singh RK, Nakra VK, Pandey HN, Arora SR. Studies of circadian periodicity of plasma, breast milk and urinary calcium in lactating Indian women. Trop Geogr Med 36: 345-349, 1984.
96. Singh RK, Bansal A, Bansal SK, Rai SP. Circadian rhythms of common laboratory profiles in serum and urine of healthy Indians. Prog Clin Biol Res 341B: 559-566, 1990.
97. Singh RK, Bansal SK, Singh AK, Mahdi AA. Circadian periodicity of urinary inhibitor of calcium oxalate crystallization in healthy Indians and renal stone farmers. Eur Urol 24: 387-392, 1993.
98. Singh R, Singh RK, Mahdi A, Misra S, Rai SP, Singh B, Cornélissen G, Halberg F. Studies of circadian periodicity of urinary corticoids in carcinoma of breast. In Vivo 12: 69-74, 1998.
99. Singh R, Singh RK, Mahdi AA, Saxena SP, Cornélissen G, Halberg F. Circadian periodicity of urinary volume, creatinine and 5-hydroxyindole acetic acid excretion in healthy Indians. Life Sci 66(3): 209-214, 2000.
100. Singh RK, Chandra R, Narang RK, Singh SK, Katiyar SK, Singh RP, Joshi LD. Circadian variations of the absolute eosinophil count and serum histaminase activity in tropical pulmonary eosinophilia. Trop Geogr Med 39: 49-52, 1987.
101. Singh RK, Singh S, Saxena S, Narang RK. Studies on circadian periodicity of plasma 17-hydroxycorticoids (17-OHCS) in tropical pulmonary eosinophilia. Prog Clin Biol Res 227B: 285-294, 1987.
102. Singh RK, Bansal A, Bansal SK. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers. Prog Clin Biol Res 227B: 305-313, 1987.
103. Singh RK, Singh S, Verma RC, Singh SK, Singh YD, Singh VB. Circadian periodicity of plasma 17-hydroxycorticoids in small cell lung carcinoma. Ind J Clin Biochem 5: 61-66, 1990.
104. Singh RK, Singh Y, Srivastava R. Circadian variations of serum urea concentrations in healthy Indians. Ind J Med Res 92(B): 257-259, 1990.
105. Singh RK, Mahdi AA, Singh AK, Bansal SK, Wu J, Zhou S, Halberg F. Circadian variation of circulating cholesterol components on vegetarian and omnivorous diets in healthy Indians. Ind J Clin Biochem 7: 185-192, 1992.
106. Singh RK, Dubey GP, Singh AK. Circadian time structure of adrenocortical function in healthy men and women. J Vivekanand Inst Med Sci 17(1): 47-53, 1994.
107. Singh RK, Mahdi AA, Singh D, Rai SP, Cornélissen G. Studies on circadian periodicity of plasma 17-hydroxycorticoids (17-OHCS) in carcinoma of breast. In Vivo 9(4): 279-284, 1995.
108. Singh RB, Pella D, Otsuka K, Halberg F, Cornélissen G. New insights into circadian aspects of health and disease. J Assoc Physicians India 50: 1416-1425, 2002.
109. Artigou JY, Salloum J, Carayon A, Lechat P, Maistre G, Isnard R, Legrand JC, Grosgogeat Y. Variations de l'endothéline plasmatique au cours du spasme coronaire. Arch Mal Coeur 86: 1581-1586, 1993.
110. Tarquini B, Pini ME, Lapucci C, Navari N, Tarquini R, Curradi C, Perfetto F. Endothelin-1 circadian acrophase: a potential co-determinant in cardiovascular chronorisk. Abstract, 21st Conference, International Society for Chronobiology, Quebec, 11-15 July 1993: XV-8.
111. Tarquini B, Perfetto F, Tarquini R, Cornélissen G, Halberg F. Endothelin-1's chronome indicates diabetic and vascular disease chronorisk. Peptides 18: 119-132, 1997.
112. Tarquini B, Cornélissen G, Perfetto F, Tarquini R, Halberg F. About-half-weekly (circasemiseptan) component of the endothelin-1 (ET-1) chronome and vascular disease risk. Peptides 18: 1237-1241, 1997.
113. Herold M, Cornélissen G, Loeckinger A, Koeberle D, Koenig P, Halberg F. About 8-hourly variation of circulating human endothelin-1 (ET-1) in clinical health. Peptides 19: 821-825, 1998.
114. Katinas GS, Halberg F, Cornélissen G, et al. About 8- and ∼84-hour rhythms in endotheliocytes as in endothelin-1 and effect of trauma. Peptides 22: 647-659, 2001.
115. Simpson HW, Bartter FC, Halberg F, Gill JR, Delea C, Gullner H-G, Haus E. A circaoctohoran rhythm of urine epinephrine excretion in man. Prog Clin Biol Res 341A: 157-160, 1990.
116. Halberg, JU. Life span, blood pressure and core temperature rhythm of rats on lighting-schedule shifts. MS Thesis, University of Minnesota, 1982, 131 pp.
117. Halberg J, Halberg E, Hayes DK, Smith RD, Halberg F, Delea CS, Danielson RS, Bartter FC. Schedule shifts, life quality and quantity modeled by murine blood pressure elevation and arthropod lifespan. Int J Chronobiol 7: 17-64, 1980.
118. Kumagai Y, Shiga T, Sunaga K, Cornélissen G, Ebihara A, Halberg F. Usefulness of circadian amplitude of blood pressure in predicting hypertensive cardiac involvement. Chronobiologia 19: 43-58, 1992.
119. Lee JY, Gillum RF, Cornélissen G, Koga Y, Halberg F. Individualized assessment of circadian rhythm characteristics of human blood pressure and pulse after moderate salt and weight restriction. In: Takahashi R, Halberg F, Walker C, eds. Toward Chronopharmacology, Proceedings of the 8th IUPHAR Congress and Satelltie Symposia, Nagasaki, July 27-28, 1981. Oxford/New York: Pergamon Press 375-390, 1982.
120. Halberg F, Cornélissen G, Halberg E, Halberg J, Delmore P, Shinoda M, Bakken E. Chronobiology of human blood pressure. In: Medtronic Continuing Medical Education Seminars, 4th edn., Minneapolis, Minnesota: Medtronic Inc, 242, 1988.
121. Gonzalez Villalpando, RC, Sanchez de la Peña S, Siegelova J, et al. Putative circadian hyper-amplitude-tension (CHAT) with MESOR-hypotension in type 2 diabetes in Mexico City. MEFA 8th International Fair of Medical Technology and Pharmacy, Brno, Czech Republic, 7-10 Nov 2000, abstract 15.
122. McKeigue PM, Marmot MG, Adelstein AM, Hunt SP, Shipley MJ, Butler SM, Riemersma RA, Turner PR. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet 2 (8464): 1086-1090, 1985.
123. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337 (8738): 382-386, 1991. [Comment in Lancet 337 (8747): 971-973, 1991.]
124. McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 35: 785-791, 1992.
125. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 87: 152-161, 1993.
126. Rao GHR (editor), Kakkar VV (associate editor). Coronary Artery Disease in South Asians: Epidemiology, risk factors and prevention. Under the aegis of the South Asian Society on Atherosclerosis and Thrombosis. New Delhi: Jaypee Brothers 322, 2001.
127. Singh RB, Tomlinson B, Thomas GN, Sharma R. Coronary artery disease and coronary risk factors: the south Asian paradox. J Nutr Environ Med 2001, 11: 43-51.
128. Pella D, Thomas GN, Tomlinson B, Singh RB. Prevention of coronary artery disease: the south Asian paradox. Lancet 2003, 361: 79.
129. Robbie L, Libby P. Inflammation and atherothrombosis. Ann NY Acad Sci 947: 167-179, 2001.
130. Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. Pharmacol Exp Ther 300(3): 729-735, 2002.
131. van der Wall AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerosis plaque is characterized by an inflammatory process of the dominant plaque morphology. Circulation 89: 36-44, 1994.
132. Falk E Shah PK, Fuster V. Coronary plaque disruption. Circulation 92: 657-671, 1995.
133. Aukrust P, Waehre T, Damas JK, Gullestad L, Solum NO. Inflammatory role of platelets in acute coronary syndromes. Heart 86: 605-606, 2001.
134. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104: 365-372, 2001.
135. Neumann FJ, Marx N, Gawaz M, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95: 2387-2394, 1997.
136. Heeschen C, Dimmeler S, Hamm CW, Fichtlseherer E, Simoons ML, Zeiher AM, for the CAPTURE Study Investigators. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107: 2109-2114, 2003.
137. Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Res 8(1): 71-86, 2003.
138. Rao GHR, Parthasarathy S. Antioxidants, atherosclerosis and thrombosis. Prostaglandins Leukot Essent Fatty Acids 54: 155-166, 1996.
139. Cohn JN. New approaches to screening for vascular and cardiac risk. Am J Hypertens 14: 2185-2205, 2001.
140. Cohn JN, Finkelstein SM. Abnormalities of vascular compliance in hypertension, aging and heart failure. J Hypertens 10: S61-S64, 1992.
141. Reinberg A, Halberg F, Ghata J, Gervais P, Abulker Ch, Dupont J, Gaudeau CI. Rythme circadien de diverses fonctions physiologiques de l'homme adulte sain, actif et au repos (pouls, pression artérielle, excrétions urinaires des 17-OHCS, des catécholamines et du potassium). Test du cosinor. J Physiol (Paris) 61 (Suppl. 2): 383, 1969.
142. Descovich GC, Montalbetti N, Kühl JFW, Rimondi S, Halberg F, Ceredi C. Age and catecholamine rhythms. Chronobiologia 1: 163-171, 1974.
143. Rao GHR, Thanikachalam S. Global assessment for coronary artery disease (CAD): Need for new guidelines for South Asians. Sci Proc SASAT 20-22, 2002.
144. Yu H, Rifai N. High sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem 33(8): 601-610, 2000.
145. Blake GJ, Ridker PM. Inflammatory mechanism in atherosclerosis: from laboratory evidence to clinical applications. Ital Heart J 2(11): 796-800, 2001.
146. Rifai N, Ridker PM. High sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47(3): 403-411, 2001.
147. Rifai N, Ridker PM. Inflammatory markers and coronary artery disease. Curr Opin Lipidol 13(4): 383-389, 2002.
148. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 89(9): 763-771, 2001.
149. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252(4): 283-294, 2002.
150. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 19(41): 537-542, 2003.
151. Huerta MG, Nadler JL. Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes. Curr Diabet Rep 2(5): 396-402, 2002.
152. Imhof A, Frohlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, Lowe GD, Koenig W. Distribution of C-reactive protein measured by high sensitivity assay in apparently healthy men and women from different population in Europe. Clin Chem 49(4): 669-672, 2003.
153. Korantzopolous P, Galaris D, Popaioannides D, Kokkoris S. C-reactive protein and oxidative stress in atrial fibrilation. Int J Cardiol 88(1): 103-104, 2003.
154. Koo BK, Choi D, Kyung HD, Jang Y, Shim WH, Cho SY. C-reactive protein in stable angina patients without peripheral vascular disease. Int J Cardiol 88(1): 105-106, 2003.
155. Pence S. Yilmaz G, Yilmaz N, Kocogh A, Namiduru E, Yuncu N, Gokalp N. C-reactive protein in patients with cerebrovascular events. Int J Clin Pract 57(2): 91-95, 2003.
156. Di Napoli M, Papa F. C-reactive protein and blood pressure in the acute phase after ischemic stroke. Stroke 34(4): 839, 2003.
157. Minetto M, Ruatta F, Angeli A. Ritmo circadiano della compliance arteriosa brachiale: un nuovo approccio diagnostico alla patologia cardiovascolare. Abstract, VI Convegno Nazionale de Cronobiologia, Chianciano, Italy, November 27-28, 1998, 20.
158. Schwabe H. Sonnen-Beobachtungen im Jahre 1843. Astronomische Nachrichten 21: 254-256 (no. 495), 1844.
159. Hale GE. Sun-spots as magnets and the periodic reversal of their polarity. Nature 113: 105-112, 1924.
160. Halberg F, Breus TK, Cornélissen G, Bingham C, Hillman DC, Rigatuso J, Delmore P, Bakken E, International Womb-to-Tomb Chronome Initiative Group: Chronobiology in space. Keynote, 37th Annual Meeting of Japanese Society for Aerospace and Environmental Medicine, Nagoya, Japan, November 8-9, 1991. University of Minnesota/Medtronic Chronobiology Seminar Series, #1, December 1991, 21 pp. of text, 70 figures.
161. Cornélissen G, Halberg F, Breus T, et al. Non-photic solar associations of heart rate variability and myocardial infarction. J Atmos Solar-Terr Phys 64: 707-720, 2002.
162. Starbuck S, Cornélissen G, Halberg F. Is motivation influenced by geomagnetic activity? Biomed Pharmacother 56 (Suppl 2): 289s-297s, 2002.
163. Starbuck S, Katinas GS, Cornélissen G, et al. Bacterial chronomics: time structures (chronomes) in sensitivity tests of antibiotics and putative helio-geomagnetic influences. Abstract 18, Proceedings, 3rd International Symposium: Workshop on Chronoastrobiology and Chronotherapy, Eriguchi M, ed, Research Center for Advanced Science and Technology, University of Tokyo, Nov. 9, 2002.
164. Mikulecky M. Periodicity of creative activities of mankind, of revolutions and of sun spots: relationships? Abstract, Man in his terrestrial and cosmic environment, Úpice, Czech Republic, 20-22 May 2003.
165. Ertel S. Space weather and revolutions: Chizhevsky's heliobiological claim scrutinized. Studia Psychologica 39: 3-22, 1996.
166. Ertel S. Bursts of creativity and aberrant sunspot cycles: hypothetical covariations. In: Nyborg H, ed. The Scientific Study of Human Nature: Tribute
167. Johnson MJ. [Address delivered by the President, M.J. Johnson, Esq., on presenting the Medal of the Society to M. Schwabe.] Monthly Notices, Royal Astronom Soc 17: 126-132, 1857.
168. Cornélissen G, Engebretson M, Johnson D, Otsuka K, Burioka N, Posch J, Halberg F. The week, inherited in neonatal human twins, found also in geomagnetic pulsations in isolated Antarctica. Biomed Pharmacother 55 (Suppl 1): 32-50, 2001.
169. Katinas G, Cornélissen G, Engebretson M, Breus T, Halberg F. A near-week in solar magnetism? Abstract 12, Proceedings, 3rd International Symposium: Workshop on Chronoastrobiology and Chronotherapy, Eriguchi M, ed, Research Center for Advanced Science and Technology, University of Tokyo, Nov. 9, 2002.
170. Biermann K-R, ed. Briefwechsel zwischen Alexander von Humboldt und Carl Friedrich Gauß: Zum 200. Geburtstag von C.F. Gauß im Auftrage des Gauß-Komitees bei der Akademie der Wissenschaften der DDR. Berlin: Akademie-Verlag 202 (+ plates), 1977.
171. Halberg F, Cornélissen G, Bingham C, et al. Season's Appreciations 2001. Neuroendocrinol Lett 23: 170-187, 2002.
172. Otsuka K, Oinuma S, Cornélissen G, et al. Alternating-light-darkness-influenced human electrocardiographic magnetor-eception in association with geomagnetic pulsations. Biomed Pharmacother 55 (Suppl 1): 63-75, 2001.
173. Carandente F, Angeli A, DeVecchi A, Dammacco F, Halberg F. Multifrequency rhythms of immunological functions. Chronobiologia 15: 7-23, 1988.
174. Wang ZR, Wan CM, Lei Y, Cornélissen G, Halberg F. Phase-zero trial of clinical chronoradiotherapy of lung cancer. Chronobiologia 21: 155-157, 1994.
175. Ulmer W, Cornélissen G, Revilla M, Siegelova J, Dusek J, Halberg F. Circadian and circaseptan dependence of the β-ATP peak of four different cancer cell cultures: implications for chronoradiotherapy. Scripta Medica (Brno) 74: 87-92, 2001.
176. Halberg E, Jardetzky N, Halberg F, Soong LB, Halberg F, Wu J, Zhou S, Jardetzky O. Magnetic resonance spectroscopy and ambulatory cardiovascular monitoring noninvasively gauge timing of phosphate metabolism and circulation. Chronobiologia 16: 1-8, 1989.
177. Halberg F, Cornélissen G, Katinas G, Hillman D, Schwartzkopff O. Season's Appreciations 2000: Chronomics complement, among many other fields, genomics and proteomics. Neuroendocrinol Lett 22: 53-73, 2001.
178. Ulmer W. On the role of the interactions of ions with external magnetic fields in physiological processes and their importance in chronobiology. In Vivo 16: 31-36, 2002.
179. Halberg F, Smith HN, Cornélissen G, Delmore P, Schwartzkopff O, International BIOCOS Group. Hurdles to asepsis, universal literacy, and chronobiology - all to be overcome. Neuroendocrinol Lett 21: 145-160, 2000.
180. Halberg F, Cornélissen G, Schack B. Self-experimentation on chronomes, time structures: chronomics for health surveillance and science: also transdisciplinary civic duty? Behav Brain Sci [Commentary on Seth Roberts. http://www.bbsonline.org/Preprints/Roberts/Commentators/.Halberg. html].
181. Halberg F, Cornélissen G, Sothern RB, Wallach LA, Halberg E, Ahlgren A, Kuzel M, Radke A, Barbosa J, Goetz F, Buckley J, Mandel J, Schuman L, Haus E, Lakatua D, Sackett L, Berg H, Wendt HW, Kawasaki T, Lieno M, Liezona K, Matsuoka M, Omae T, Tarquini B, Cagnoni M, Garcia Sainz M, Perez Vega E, Wilson D, Griffiths K, Donati L, Tatti P, Vasta M, Locatelli I, Camagna A, Lauro R, Tritsch G, Wetterberg L. International geographic studies of oncological interest on chronobiological variables. In: Kaiser H, editor. Neoplasms - Comparative Pathology of Growth in Animals, Plants and Man. Baltimore: Williams and Wilkins 553-596, 1981.
182. Halberg E, Halberg F, Cornélissen G, Garcia-Sainz M, Simpson HW, Taggett-Anderson MA, Haus E. Toward a chronopsy: Part II. A thermopsy revealting asymmetrical circadian variation in surface temperature of human female breasts and related studies. Chronobiologia 6: 231-257, 1979.
183. Simpson HW. Sir James Young Simpson Memorial Lecture 1995. Breast cancer prevention: a pathologist's approach. J R Coil Surg Edinb 41: 339-370, 1996.
184. Hrushesky WJM, Langer R, Theeuwes F, editors. Temporal Control of Drug Delivery. Ann NY Acad Sci 618: 1991.
185. Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiology International 19: 237-251, 2002.
186. Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 97: 155-169, 2003.